Advisor Group’s 10x Genomics TXG Stock Holding History

Advisor Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$2K	Buy	+28	New	+$1.68K	﹤0.01%	5028

Other funds holding TXG

FCMI

Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

JCM

JS Capital Management New York $223M AUM 104.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Advisor Group's TXG Position: Q4 2019 in Review

Advisor Group opened a new position in 10x Genomics (TXG) in Q4 2019: 28 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #5028 among its holdings.

85 funds tracked by Wall St. Rank hold TXG as of Q4 2019.

Advisor Group held 28 shares of 10x Genomics worth $2K as of Q4 2019.
10x Genomics was a new Advisor Group position in Q4 2019.
10x Genomics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5028 holding.
85 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.